ORLANDO, FL. — September 23, 2026 — NextTrial, a provider of a unified intelligence platform and solutions for the life sciences industry, today announced the appointment of Peter Leister as Chief Commercial Officer.
The appointment comes as NextTrial continues to experience strong growth and increasing market momentum across its platform and solutions.
Peter brings extensive commercial leadership and life sciences experience spanning technology, business transformation, and enterprise solutions. He previously served as Chief Commercial Officer at ArisGlobal and held leadership roles at Genpact, Accenture, and IBM. As an independent consultant and board member, he has also supported global businesses through turnarounds, M&A activities, and successful exits.
“We are very pleased to welcome Peter to NextTrial at an important stage in our growth,” said Sharad Prakash, Founder and CEO of NextTrial. “Peter brings the commercial leadership, life sciences expertise, and industry perspective to help us scale globally and bring NextTrial’s capabilities to more organizations.”
As Chief Commercial Officer, Peter will lead NextTrial’s global commercial strategy, including business development, strategic partnerships, and market expansion.
“Life sciences organizations are under increasing pressure to modernize complex operations while maintaining the trust and control required in a highly regulated industry,” said Peter Leister, Chief Commercial Officer at NextTrial. “NextTrial has built a compelling platform and portfolio of solutions to address these challenges, and I’m excited to help expand its reach and impact.”
NextTrial continues to expand NextTrial One, its unified intelligence platform for life sciences, which brings together data, workflows, intelligence, and AI to help organizations build and scale intelligent business solutions without replacing their core systems.
Built on NextTrial One, the company’s solution portfolio includes Study 360 for clinical operations, Total Safety Intelligence for pharmacovigilance and drug safety, and Regulatory Navigator for regulatory operations and intelligence.
About NextTrial
NextTrial is a life sciences technology company transforming how organizations harness data and intelligence to enable faster decisions, stronger outcomes, and improved patient safety. Through its NextTrial One platform, organizations can accelerate clinical development, strengthen product safety profiles, and improve regulatory compliance across clinical, safety, and regulatory operations. NextTrial is headquartered in Orlando, Florida, with regional offices in Bridgewater, New Jersey, and Bangalore, India.